WHO ICTRP trial

LOCALIZED HIGH-RISK SOFT TISSUE SARCOMAS OF THE EXTREMITIES AND TRUNK WALL IN…

EUCTR2010-023484-17-IT · EU Clinical Trials Register · Not Recruiting

Key facts

Trial ID EUCTR2010-023484-17-IT
Public title LOCALIZED HIGH-RISK SOFT TISSUE SARCOMAS OF THE EXTREMITIES AND TRUNK WALL IN ADULTS: AN INTEGRATING APPROACH COMPRISING STANDARD VS HISTOTYPE-TAILORED NEOADJUVANT CHEMOTHERAPY (ISG-STS 10-01) - ND
Scientific title LOCALIZED HIGH-RISK SOFT TISSUE SARCOMAS OF THE EXTREMITIES AND TRUNK WALL IN ADULTS: AN INTEGRATING APPROACH COMPRISING STANDARD VS HISTOTYPE-TAILORED NEOADJUVANT CHEMOTHERAPY (ISG-STS 10-01) - ND
Primary sponsor ITALIAN SARCOMA GROUP
Registry EU Clinical Trials Register
Recruitment status Not Recruiting
Study type Interventional clinical trial of medicinal product
Phase Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): yes Therapeutic use (Phase IV): no
Countries Poland;Spain;Italy
Conditions High risk localized soft tissue sarcomas typical of the adult MedDRA version: 9.1 Level: HLGT Classification code 10041299
Interventions Pharmaceutical Form: Solution for infusion INN or Proposed INN: Epirubicin Concentration unit: mg milligram(s) Concentration type: equal Concentration number: 50- Pharmaceutical Form: Solution for infusion INN or Proposed INN: Gemcitabine…
Registration date Mar 2, 2011
Target size 300
Secondary IDs 2010-023484-17
Registry page clinicaltrialsregister.eu

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations